|
|
Volumn 18, Issue 6, 2004, Pages 951-952
|
|
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD3 ANTIGEN;
CYCLIC AMP;
INDOMETACIN;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROFECOXIB;
ADULT;
ARTICLE;
CELL FUNCTION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG RESPONSE;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE PROLIFERATION;
MALE;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
STATISTICAL SIGNIFICANCE;
T LYMPHOCYTE;
ADULT;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CELL DIVISION;
CYCLOOXYGENASE INHIBITORS;
FEMALE;
HIV INFECTIONS;
HUMANS;
INDOMETHACIN;
LACTONES;
LYMPHOCYTE COUNT;
MALE;
MIDDLE AGED;
SULFONES;
T-LYMPHOCYTES;
VIRAL LOAD;
|
|
EID: 2142819981
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200404090-00015 Document Type: Article |
|
Times cited : (16)
|
|
References (6)
|
